These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 2845714

  • 1. Adrenal cortex and type II polycystic ovary syndrome.
    Devesa J, Perez-Fernandez R, Lima L, Cabezas-Cerrato J.
    Gynecol Endocrinol; 1987 Sep; 1(3):269-77. PubMed ID: 2845714
    [Abstract] [Full Text] [Related]

  • 2. Adrenal abnormalities in polycystic ovary syndrome.
    Loughlin T, Cunningham S, Moore A, Culliton M, Smyth PP, McKenna TJ.
    J Clin Endocrinol Metab; 1986 Jan; 62(1):142-7. PubMed ID: 3079598
    [Abstract] [Full Text] [Related]

  • 3. Adrenal function in hirsutism I. Diurnal change and response of plasma androstenedione, testosterone, 17-hydroxyprogesterone, cortisol, LH and FSH to dexamethasone and 1/2 unit of ACTH.
    Givens JR, Andersen RN, Ragland JB, Wiser WL, Umstot ES.
    J Clin Endocrinol Metab; 1975 Jun; 40(6):988-1000. PubMed ID: 166091
    [Abstract] [Full Text] [Related]

  • 4. Circulating levels of plasma adrenocorticotropin in polycystic ovary disease.
    Chang RJ, Mandel FP, Wolfsen AR, Judd HL.
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1265-7. PubMed ID: 6281296
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. 17-Hydroxyprogesterone response to buserelin testing in the polycystic ovary syndrome.
    Sahin Y, Keleştimur F.
    Clin Endocrinol (Oxf); 1993 Aug; 39(2):151-5. PubMed ID: 8396511
    [Abstract] [Full Text] [Related]

  • 7. Gonadotrophin and gonadal steroid response to a single dose of a long-acting agonist of gonadotrophin-releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome.
    White D, Leigh A, Wilson C, Donaldson A, Franks S.
    Clin Endocrinol (Oxf); 1995 May; 42(5):475-81. PubMed ID: 7621565
    [Abstract] [Full Text] [Related]

  • 8. Assessment of the adrenal-ovarian contribution by short-term dexamethasone and ACTH tests in hyperandrogenized patients.
    Fulghesu AM, Lanzone A, Apa R, Fortini A, Caruso A, Mancuso S.
    Gynecol Endocrinol; 1991 Mar; 5(1):37-48. PubMed ID: 1654730
    [Abstract] [Full Text] [Related]

  • 9. Source localization of androgen excess in adolescent girls.
    Ibáñez L, Potau N, Zampolli M, Prat N, Gussinyé M, Saenger P, Vicens-Calvet E, Carrascosa A.
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1778-84. PubMed ID: 7989484
    [Abstract] [Full Text] [Related]

  • 10. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
    Rittmaster RS, Thompson DL.
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
    [Abstract] [Full Text] [Related]

  • 11. Adrenal function in subgroups of the PCO syndrome assessed by a long ACTH test.
    Kandeel FR, London DR, Butt WR, Davila N, Rudd BT, Sadeghian S, Lynch SS, Edwards RL, Horder M.
    Clin Endocrinol (Oxf); 1980 Dec; 13(6):601-12. PubMed ID: 6261995
    [Abstract] [Full Text] [Related]

  • 12. Differential androgen response to adrenocorticotropic hormone stimulation in polycystic ovarian syndrome: relationship with insulin secretion.
    Lanzone A, Fulghesu AM, Guido M, Fortini A, Caruso A, Mancuso S.
    Fertil Steril; 1992 Aug; 58(2):296-301. PubMed ID: 1321739
    [Abstract] [Full Text] [Related]

  • 13. [Effects of bromocriptine on endocrine environment in the polycystic ovary syndrome].
    Huang HJ, Ishimaru T, Yamabe T.
    Nihon Naibunpi Gakkai Zasshi; 1988 Apr 20; 64(4):265-78. PubMed ID: 3136040
    [Abstract] [Full Text] [Related]

  • 14. Ovarian 17-ketosteroid reductase deficiency as a possible cause of polycystic ovarian disease.
    Toscano V, Balducci R, Bianchi P, Mangiantini A, Sciarra F.
    J Clin Endocrinol Metab; 1990 Aug 20; 71(2):288-92. PubMed ID: 2166066
    [Abstract] [Full Text] [Related]

  • 15. [Partial deficiency in 21-hydroxylase in certain forms of hirsutism].
    Lucisano A, Satta MA, Tripodi R, Mobili L, De Cicco F, Monaco F, Dell'Acqua S, Roche J.
    C R Seances Soc Biol Fil; 1989 Aug 20; 183(2):117-21. PubMed ID: 2555033
    [Abstract] [Full Text] [Related]

  • 16. Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome.
    Barnes RB, Rosenfield RL, Burstein S, Ehrmann DA.
    N Engl J Med; 1989 Mar 02; 320(9):559-65. PubMed ID: 2521688
    [Abstract] [Full Text] [Related]

  • 17. Scintigraphic evidence of adrenal cortical dysfunction in the polycystic ovary syndrome.
    Gross MD, Wortsman J, Shapiro B, Meyers LC, Woodbury MC, Ayers JW.
    J Clin Endocrinol Metab; 1986 Jan 02; 62(1):197-201. PubMed ID: 3079601
    [Abstract] [Full Text] [Related]

  • 18. Lack of linear relationship between hyperinsulinaemia and hyperandrogenism.
    Toscano V, Bianchi P, Balducci R, Guglielmi R, Mangiantini A, Lubrano C, Sciarra F.
    Clin Endocrinol (Oxf); 1992 Feb 02; 36(2):197-202. PubMed ID: 1533185
    [Abstract] [Full Text] [Related]

  • 19. Accelerated 24-hour luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovarian syndrome.
    Apter D, Bützow T, Laughlin GA, Yen SS.
    J Clin Endocrinol Metab; 1994 Jul 02; 79(1):119-25. PubMed ID: 8027216
    [Abstract] [Full Text] [Related]

  • 20. Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia: does idiopathic hirsutism exist?
    Escobar-Morreale HF, Serrano-Gotarredona J, García-Robles R, Sancho J, Varela C.
    Metabolism; 1997 Aug 02; 46(8):902-7. PubMed ID: 9258272
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.